- Record: found
- Abstract: not found
- Article: not found
A randomized phase III trial of DX-8951f (Exatecan Mesylate; DX) and Gemcitabine (GEM) vs Gemcitabine alone in advanced pancreatic cancer (APC)
E. Reilly, GK Abou-Alfa, R. Letourneau, WG Harker, M Modiano, H Hurwitz, NS Tchekmedyian, J Ackerman, R Jager, SG Eckhardt
2004
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.